Whole-Exome Sequencing Reveals Overlap Between Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis and Familial Hemophagocytic Lymphohistiocytosis

Arthritis and Rheumatology

Volumn 66, Issue 12, 2014, Pages 3486-3495

  Kaufman, Kenneth M ^a   Linghu, Bolan ^a   Szustakowski, Joseph D ^a   Husami, Ammar ^a   Yang, Fan ^a   Zhang, Kejian ^a   Filipovich, Alexandra H ^a   Fall, Ndate ^a   Harley, John B ^a   Nirmala, N R ^a   Grom, Alexei A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOGLOBULIN; RITUXIMAB; THYMOCYTE ANTIBODY;

ADOLESCENT; ARTICLE; CELL FUNCTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EXOME; FEMALE; GENE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEMOPHAGOCYTIC SYNDROME; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; INDEL MUTATION; JUVENILE RHEUMATOID ARTHRITIS; LYST GENE; MACROPHAGE ACTIVATION SYNDROME; MALE; MICROTUBULE; MUNC13-4 GENE; PROTEIN ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STXBP2 GENE; COMPLICATION; DNA SEQUENCE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; INFANT; MUTATION; PARENT; PRESCHOOL CHILD;

ADOLESCENT; ARTHRITIS, JUVENILE; CHILD; CHILD, PRESCHOOL; EXOME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MACROPHAGE ACTIVATION SYNDROME; MALE; MUTATION; PARENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 84912047373     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38793     Document Type: Article

References (50)

1. Ravelli A, Martini A,. Juvenile idiopathic arthritis. Lancet 2007; 369: 767-78.
2. Schneider R, Laxer RM,. Systemic onset juvenile rheumatoid arthritis. Baillieres Clin Rheumatol 1998; 12: 245-71.
3. Mellins ED, Macubas C, Grom AA,. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol 2011; 7: 416-26.
4. Hadchouel M, Prieur AM, Griscelli C,. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr 1985; 106: 561-6.
5. Grom AA,. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? [review] Arthritis Rheum 2004; 50: 689-98.
6. Sawhney S, Woo P, Murray KJ,. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001; 85: 421-6.
7. Moradinejad MH, Ziaee V,. The incidence of macrophage activation syndrome in children with rheumatic disorders. Minerva Pediatr 2011; 63; 459-66.
8. Athreya BH,. Is macrophage activation syndrome a new entity? Clin Exp Rheumatol 2002; 20: 121-3.
9. Filipovich AH,. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program 2009; 127-31.
10. Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LM, Arico M, et al. Contemporary classification of histiocytic disorders. Med Pediatr Oncol 1997; 29: 157-66.
11. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-31.
12. Zhang K, Jordan MB, Marsh RA, Johnson JA, Kissell D, Meller J, et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood 2011; 118: 5794-8.
13. Lopez JA, Brennan AJ, Whisstock JC, Voskoboinik I, Trapani JA,. Protecting a serial killer: pathways for perforin trafficking and self-defence ensure sequential target cell death. Trends Immunol 2012; 33: 406-12.
14. Stinchcombe JC, Griffiths GM,. Secretory mechanisms in cell-mediated cytotoxicity. Annu Rev Cell Dev Biol 2007; 23: 495-517.
15. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999; 286: 1957-9.
16. Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 2003; 115: 461-73.
17. Zur Stadt U, Schmidt S, Kasper B, Beutel K, Diler AS, Henter JI, et al. Linkage of familial hemophagocytic lymphohistiocytosis type 4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet 2005; 14: 827-34.
18. Zur Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet 2009; 85: 482-92.
19. Menasche G, Pastural E, Feldmann J, Certain S, Ersoy F, Dupuis S, et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 2000; 25: 173-6.
20. Barbosa MD, Nguyen QA, Tchernev VT, Ashley JA, Detter JC, Blaydes SM, et al. Identification of the homologous beige and Chediak-Higashi syndrome genes [published erratum appears in Nature 1997;385:97]. Nature 1996; 382: 262-5.
21. Coffey AJ, Brooksbank RA, Brandau O, Oohashi T, Howell GR, Bye JM, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 1998; 20: 129-35.
22. Marsh RA, Madden L, Kitchen BJ, Mody R, McClimon B, Jordan MB, et al. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood 2010; 116: 1079-82.
23. Menasche G, Feldmann J, Fischer A, de Saint Basile G,. Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunol Rev 2005; 203: 165-79.
24. Kagi D, Odermatt B, Mak TW,. Homeostatic regulation of CD8+ T cells by perforin. Eur J Immunol 1999; 29: 3262-72.
25. Lykens JE, Terrell CE, Zoller EE, Risma K, Jordan MB,. Perforin is a critical physiologic regulator of T-cell activation. Blood 2011; 118: 618-26.
26. Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A,. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 2003; 142: 292-6.
27. Vastert SJ, van Wijk R, D'Urbano LE, de Vooght KM, de Jager W, Ravelli A, et al. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford) 2010; 49: 441-9.
28. Hazen MM, Woodward AL, Hofmann I, Degar BA, Grom AA, Filipovich AH, et al. Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis. Arthritis Rheum 2008; 58: 567-70.
29. Zhang K, Biroschak J, Glass DN, Thompson SD, Finkel T, Passo MH, et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis Rheum 2008; 58: 2892-6.
30. Glass DN, Giannini EH,. Juvenile rheumatoid arthritis as a complex genetic trait [review]. Arthritis Rheum 1999; 42: 2261-8.
31. Ombrello MJ, Remmers E, Grom AA, Thomson W, Martini A, Gattorno M, et al. Major histocompatibility class II gene cluster harbors systemic juvenile idiopathic arthritis susceptibility locus [abstract]. Arthritis Rheum 2011; 63 Suppl: S659-60.
32. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 2001; 43: 491-8.
33. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, et al. Exome sequencing identifies the cause of a Mendelian disorder. Nat Genet 2010; 42: 30-5.
34. Chahrour MH, Yu TW, Lim ET, Ataman B, Coulter ME, Hill RS, et al. Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism. PLoS Genet 2012; 8: e1002635.
35. Vissers LE, de Ligt J, Gilissen C, Janssen I, Steehouwer M, de Vries P, et al. A de novo paradigm for mental retardation. Nat Genet 2010; 42: 1109-12.
36. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012; 485: 237-41.
37. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998; 25: 1991-4.
38. Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005; 146: 598-604.
39. Li H, Durbin R,. Fast and accurate short read alignment with Burrows-Wheeler transformation. Bioinformatics 2009; 25: 1754-60.
40. Behrens EM, Beukelman T, Paessler M, Cron RQ,. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 2007; 34: 1133-8.
41. Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor α-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007; 56: 965-71.
42. Fukuda T, Sugita S, Inatome R, Yanagi S,. CAMDI, a novel disrupted in schizophrenia 1 (DISC1)-binding protein, is required for radial migration. J Biol Chem 2010; 285: 40554-61.
43. FHIP complex interacts with and promotes endosomal clustering by the homotypic vacuolar protein sorting complex. Mol Biol Cell 2008; 19: 5059-71.
44. Pacholsky D, Vakeel P, Himmel M, Lowe T, Stradal T, Rottner K, et al. Xin repeats define a novel actin-binding motif. J Cell Sci 2004; 117: 5257-68.
45. Kuroda TS, Fukuda M, Ariga H, Mikoshiba K,. The Slp homology domain of synaptotagmin-like proteins 1-4 and Slac2 functions as a novel Rab27A binding domain. J Biol Chem 2002; 277: 9212-8.
46. D'Souza-Schorey C, Chavrier P,. ARF proteins: role in membrane traffic and beyond. Nat Rev Mol Cell Biol 2006; 7: 347-58.
47. Zhou Y, Gunput RA, Adolfs Y, Pasterkamp RJ,. MICALs in control of the cytoskeleton, exocytosis, and cell death. Cell Mol Life Sci 2011; 68: 4033-44.
48. 2+-dependent activator for secretion protein family. Genomics 2003; 81: 279-91.
49. Benedict CA, Ware CF,. TRAIL: not just for tumors anymore? J Exp Med 2012; 209: 1903-6.
50. D'Adamo P, Menegon A, Lo Nigro C, Grasso M, Gulisano M, Tamanini F, et al. Mutations in GDI1 are responsible for X-linked non-specific mental retardation. Nat Genet 1998; 19: 134-9.